Biosynthesis of very long chain (>C18) fatty acids (VLCFAs) and the pathway for their incorporation into acyl liipids was studied in microspore-derived (MD) inantly at the sn-3 position, but were also found at the sn-1 position.
[14C120:1, but not [14C]22:1, was detected at the sn-2 position. Similar patterns of 14C-labeled VLCFA distribution were obtained in experiments conducted using a 15,000g pellet fraction from 18- day MD embryos. All trends observed in the formation of TAGs containing VLCFAs in the Reston MD embryo system were also confirmed in studies of zygotic embryos of the same cultivar. The data support the biosynthesis of 20:1 and then 22 :1 via successive condensations of malonyl-coenzyme A with oleoyl-coenzyme A and, for the first time in B. napus, demonstrate the incorporation of newly synthesized VLCFAs into TAGs via the Kennedy pathway.
Oilseeds of the Brassicaceae contain TAGs4 rich in VLCFAs such as eicosenoic (20:1), erucic (22:1), and nervonic (24:1) acids (2) . Early studies based mainly on ["4C]acetate feedings in developing seeds of Brassica napus (12) and other oilseeds (3, 17, 21, 22) indicated that VLCFAs were formed by successive 2-carbon chain extensions of oleic acid. It is now generally accepted that the biosynthesis of VLCFAs occurs via condensation of 18:1-CoA with malonyl-CoA, as has been demonstrated in vivo in B. juncea and B. campestris (23) , and in homogenates or particulate fractions from developing seeds of B. juncea (1, 23), Arabidopsis thaliana (15) , Lunaria annua, Tropaeolum majus, and Sinapis alba (19) .
Although it is clear that in higher plants, C16 and C18 fatty acids are incorporated into TAGs via the G-3-P pathway according to Kennedy (5, 24) , the mechanism involved in the biosynthesis of TAGs containing VLCFAs is not fully understood, despite a number of studies to elucidate the pathway in various developing oilseeds (4, 6, 7, 13, 18, 25) . Recently, however, it was suggested that the biosynthesis of TAGs containing VLCFAs in L. annua and S. alba occurs via a mechanism involving rapid elongation of 18:1-CoA in the presence of malonyl-CoA to yield 20:1, 22:1, and 24:1 moieties, which are subsequently incorporated into TAGs via the Kennedy pathway (14) .
In the course of our investigations of TAG bioassembly in MD embryos of B. napus L. using a high erucic acid cultivar, Reston, we have found these embryos to be very active in the synthesis and metabolism of erucoyl moieties (27, 28, (30) (31) (32) . Thus, as a natural progression of these studies, we report here for the first time investigations of the in vitro capacity for VLCFA biosynthesis and the mechanism by which these newly synthesized fatty acids accumulate in TAGs in the B.
napus MD embryo system. Comparisons are made with zygotic embryos of the same cultivar.
MATERIALS AND METHODS Lipid Substrates and Biochemicals
[1-14C]Erucic acid (52 mCi mmol-') was purchased from NEN Research Products (Mississauga, Ontario) and [1-"C] oleic acid (58 mCi-mmol-1) and [2-"'C]malonyl-CoA (55.0 mCi. mmol-') were purchased from Amersham Canada Ltd. (Oakville, Ontario). [1-"'C]eicosenoyl-CoA (52.8 mCi* mmol-1) was synthesized as described below.
All 1-'4C-fatty acids were converted to acyl-CoAs by an enzymic method described previously (29) . Unlabeled acyl-CoAs, polyvinylpolypyrrolidone, ATP, CoA, NADH, NADPH, and most other biochemicals were purchased from Sigma. Neutral lipid standards were obtained from NuChek Prep, Inc. (Elysian, MN), and polar lipids were purchased from Sigma. HPLC-grade solvents (Omni-Solv, BDH Chemicals, Toronto, Ontario) were used throughout these studies.
Synthesis of [1 -14Ccis-1 1-Eicosenoyl-CoA Preparation of cis-1 O-Nonadecenol Tosylate
To a solution of methyl-cis-10-nonadecenoate (NuChek) (87 mg, 0.28 mmol) in 0.5 mL of tetrahydrofuran was added 0.32 mmol (95 gL) Red-al (3.4 M sodium bis-(2-methoxyethoxy) aluminum hydride in toluene [Aldrich Chemical Co., Milwaukee, WI]). The mixture was stirred for 2 h, at which time GC analysis showed >99% conversion to the alcohol. The reaction mixture was added slowly to 20 mL of dilute HCl and the product extracted with 3 x 20 mL of hexane. Removal of the hexane afforded 73 mg (92%) of cis-10-nonadecenol. This alcohol was converted to the tosylate (16) by treating the alcohol (27 mg, 0.1 mmol) in 150 ,uL of dry pyridine with para-tosyl chloride (40 mg, 0.2 mmol) in 50 ,uL of pyridine. The mixture, maintained at 0 to 50C under nitrogen, was stirred overnight. TLC (20% ether in hexane) showed traces of the alcohol at RF 0.07 and the product at RF 0.58. The mixture was poured into ice water (20 mL) and extracted with ether (3 x 20 mL). The combined ether extracts were successively washed with water (2 x 20 mL), a 1 % CUSO4 solution (2 x 20 mL), a 10% NaHCO3 solution, and brine and then dried over anhydrous MgSO4. Removal of the solvent afforded the crude tosylate (41 mg, 97% yield).
Synthesis of [1 -14C]cis-11 -Eicosenoyl Nitrile
The nitrile was formed from the tosylate by reaction with Na'4CN (16) . To an excess of tosylate (10 mg, 23 ,tmol) in 50 ,uL of DMSO under a nitrogen atmosphere was added an alkaline solution of Na14CN (0.25 mg, 5.1 ,umol 0.27 mCi).
The reaction was stirred for 72 h at room temperature and extracted into hexane (10 x 2 mL), and the combined extract was washed with brine, dried over anhydrous MgSO4, and counted (0.22 mCi). TLC (11) . To the total labeled nitrile in a 10-mL flask fitted with a condenser and maintained under nitrogen was added ethanol (1 mL), 30% aqueous KOH (1 mL), and 30% H202 (300 goL). The mixture was stirred and slowly heated to 400C over 1 h and then to 800C overnight. The mixture was cooled to room temperature and the amount of acid formed was monitored by TLC on Silica Gel G. The developing solvent was ether:hexane (20:80, v/v); RF of the acid was 0.0 and that of nitrile was 0.48. At this time, the conversion of the nitrile to the acid was only approximately 25%. The addition of H202 (300 ,uL) and ethanol (1 mL) followed by overnight incubation at 800C was repeated twice, after which the conversion of the nitrile to the acid was 90%, as monitored by TLC. The reaction mixture was saturated with NaCl and extracted into ether (5 x 20 mL), and the solvent was dried over anhydrous MgSO4 and removed under a stream of nitrogen. The acid was esterified with 1 N methanolic HCl (see below). The reaction product was purified by radio-HPLC as described below, but eluted using a linear gradient from 100% acetonitrile to 100% acetone. Two radioactive fractions were collected, the first containing unreacted nitrile (7-8 min, 7.2 ,uCi) and the second containing the methyl ester (10-12 min, 77 ,uCi). To measure total elongation capacity, reactions were stopped by adding 3 mL of 5% (w/v) KOH in methanol and the tubes capped and heated at 800C for 2 h to saponify the acyl lipids and acyl-CoAs. The tubes were cooled on ice and the contents were acidified with 1 mL of 6 N HCl and extracted three times with 2 mL of hexane. The combined hexane extract containing the 14C free fatty acids was dried under nitrogen, and the fatty acids were transmethylated in the presence of 1 N methanolic HCl as described above. The "4C methyl esters were then separated and quantified by radio-HPLC.
Radio-HPLC Analysis
The system consisted of an SP8700 liquid chromatograph (Spectra Physics, San Jose, CA) furnished with a Rheodyne 7125 injector (200 ML loop) (Rheodyne, Cotati, CA), an ACS model 750/14 evaporative analyzer (Applied Chromatography Systems Ltd., Macclesfield, Cheshire, UK) and a FloOne/Beta radioactive flow detector and data processing program (Radiomatic Instruments and Chemical Co., Tampa, FL). The HPLC columns consisted of a Whatman RP guard cartridge followed by two Whatman PartiSphere C18 5-,um reverse-phase cartridges (4.6 mm i.d. x 12.5 cm) (Whatman Inc., Clifton, NJ) in series. The two mobile phase solvents were acetonitrile and acetone. The FAMEs were separated and eluted with a linear gradient from 100% acetonitrile to 50% acetonitrile/50% acetone over 20 min. After a 5-min isocratic period in the latter solvent mixture, the column was reequilibrated to 100% acetonitrile over 5 min. The HPLC flow rate was 1 mL/min, and the column effluent was mixed with scintillant (toluene containing 0.4% [w/v] 2,5-diphenyloxazole [PPO; New England Nuclear]) at a rate of 2 mL/min before entering the Flo-One/Beta detector. Radiolabeled FAMEs were identified by cochromatography with external FAME standards (Supelco Standard FAME Mix No. 4 and was utilized in some of the studies described below. In other developing oilseeds, this fraction has also been reported to be similarly enriched (14, 19) . to make a reasonable comparison of the reaction rates. The authors attributed the observed differences to the availability of endogenous versus exogenous acyl-CoA primers at the reactive site of the elongase(s) (19) . However, in the current study, exogenous unlabeled malonyl-CoA was essential for VLCFA biosynthesis in vitro (cf . Table II) and, thus, appears to be able to access the site of elongation. Because isotope discrimination is an unlikely possibility, the apparent discrepancy in reaction rates obtained, depending on the radiolabeled thioester supplied, might be caused by differences in the specificity or Homogenates assayed in vitro showed an absolute requirement for exogenously supplied malonyl-CoA for the biosynthesis and incorporation of 1"C-labeled VLCFAs into acyl lipids (Table II) (Table III) . The values in Table III 
MD Embryo Studies
Earlier in vitro studies (28) (Table IV) .
Time-course experiments were conducted using the [14C]18:1-CoA + malonyl-CoA reaction system in the presence of G-3-P with both homogenate (Fig. 2) and 15,000g particulate (Fig. 3) fractions from 18-d cultured MD embryos. In the homogenate studies (Fig. 2) CoA with malonyl-CoA, followed by incorporation of the very long-chain acyl-CoAs into glycerolipids, as demonstrated in other developing oilseeds (13, 14, 19) . In general, 14C-VLCFA levels in TAGs were at least 1 order of magnitude greater than in all other glycerolipid pools at any time. Increases in VLCFAs in the FFA pool were likely due to thioesterase activity present in the extracts. Hydrolytic activity was greatest on erucoyl-CoA, consistent with earlier findings (28) . It is interesting that newly synthesized VLCFAs were found in the PC/lyso-phosphatidylcholine pool throughout the time course. They were not detected at a significant level in LPE, PE, or other complex polar lipids (data not shown).
Parallel metabolic experiments conducted using a 15,000g particulate fraction showed trends similar to those observed in the homogenate fraction. The 15,000g pellet fraction contained 40 to 50% of the total elongation/incorporation activity found in the homogenate. However, on a per mg protein basis, rates for incorporation of radiolabeled, newly synthesized VLCFAs into the various glycerolipid, acyl-CoA, and FFA pools were higher by at least 1 order of magnitude in the 15,000g pellet studies (Fig. 3) as compared with the homogenate studies (Fig. 2) , indicating that essentially all elongation and incorporation (Kennedy pathway) enzymes required for TAG bioassembly (as well as thioesterases) were present in the particulate fraction. The total elongation/ incorporation capacity (12.2 nmol-mg-1 protein-h-') was in (Fig. 3) .
Although VLCFAs, and erucoyl moieties in particular, do not accumulate in the endogenous LPA/PA and PC pools of developing MD embryos of B. napus cv Reston (28) , the present data suggest that, rather than being excluded from polar lipid intermediates of the currently accepted TAG bioassembly pathway (24) , newly synthesized VLCFAs may be channeled very rapidly from G-3-P through LPA, PA, DAG 20 LPA / PA CoA, reducing equivalents, and G-3-P, VLCFAs were biosynthesized and were incorporated into glycerolipids of the Kennedy pathway in a manner similar to that observed in the MD embryo studies (Table V) . Again, VLCFAs accumulated primarily in the TAG fraction, but were also detected in the LPA, PA, DAG, PC, and FFA pools. Similar trends have recently been reported in studies of other developing oilseeds of the Brassicaceae (14) . In the present study, rates of total VLCFA biosynthesis and incorporation into acyl lipids in vitro were similar in zygotic Reston embryos (600-750 pmol -mg-' protein. h-') and the MD embryo system (600-1000 pmol-mg-1 protein h-'). However, given the ease of accessing embryos at specific stages of development (28), the MD embryo system is preferred for B. napus experimentation.
Stereospecific Analyses of '4C-Labeled TAGs
The high TAG biosynthetic capacity of the MD embryo system in vitro resulted in TAGs strongly labeled with '4C-VLCFAs and afforded the opportunity to perform complex, multi-step modified Brockerhoff stereospecific analyses (10) on the '4C-TAGs. The result is that, for the first time, all (13, 14) . (28) and zygotic embryos (7, 9, 20, 28) . Furthermore, the in vitro results confirm that the LPA acyltransferase (EC 2.3.1.5 1) in B. napus is incapable of inserting newly synthesized erucoyl moieties at the sn-2 position on the glycerol backbone (25, 26 CONCLUSIONS The present data are the first evidence to support strongly the Kennedy pathway as the mechanism for incorporation of VLCFAs, and erucoyl moieties in particular, into both the sn-1 and sn-3 positions of TAGs in developing MD and zygotic embryos of B. napus. The bioassembly of TAGs containing VLCFAs appears to be intimately linked to their biosynthesis by successive condensations of malonyl-CoA with 18:1-CoA. The data suggest a rapid turnover or channeling of Kennedy pathway intermediates allowing an accumulation of TAGs enriched in VLCFAs at the sn-i and sn-3 positions, as demonstrated for the first time by Brockerhoff stereospecific positional analyses. These findings support previous studies conducted in L. annua and S. alba (14) . The MD embryo system of B. napus cv Reston continues to be a highly active experimental system for the in vitro study of VLCFA biosynthesis and TAG bioassembly.
